Indo National Intrinsic Value
Indo National (NIPPOBATRY) median intrinsic value is ₹907.25 from 3 valuation models (range ₹726–₹907), vs current price ₹362.90 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. Browse Indo National financial data for revenue, profit, balance sheet and cash flow data.
NIPPOBATRY Valuation Methods Summary — DCF, Graham Number & P/E
Indo National intrinsic value across 3 models vs current price ₹362.90 — upside/downside and value range per method. Also explore NIPPOBATRY stock price history to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹907.25 | ₹816.52 - ₹997.98 | +150.0% | Book Value/Share: ₹757.50, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹725.80 | ₹653.22 - ₹798.38 | +100.0% | Revenue/Share: ₹1090.00, P/S: 1.5x |
| Simple DCF (5Y) | dcf | ₹907.25 | ₹725.80 - ₹1088.70 | +150.0% | CF Growth: 15.0%, Discount: 15% |
NIPPOBATRY Intrinsic Value vs Market Price — All Valuation Models
Indo National fair value range ₹726–₹907 vs current market price ₹362.90 across 3 valuation models. For current market price and key ratios, visit NIPPOBATRY share price.
NIPPOBATRY Intrinsic Value Analysis — Undervalued or Overvalued?
Indo National median intrinsic value ₹907.25, current price ₹362.90 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.
What is the intrinsic value of NIPPOBATRY?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Indo National (NIPPOBATRY) is ₹907.25 (median value). With the current market price of ₹362.90, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹725.80 to ₹907.25, indicating ₹725.80 - ₹907.25.
Is NIPPOBATRY undervalued or overvalued?
Based on our multi-method analysis, Indo National (NIPPOBATRY) appears to be trading below calculated value by approximately 150.0%.
NIPPOBATRY Financial Health — Key Ratios vs Industry Benchmarks
Indo National financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 6.86 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -27.7% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -17.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.01x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
NIPPOBATRY Cash Flow Quality — Operating & Free Cash Flow
Indo National operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-56 Cr | ₹-56 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹44 Cr | ₹25 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹36 Cr | ₹22 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹35 Cr | ₹18 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹11 Cr | ₹11 Cr | Positive Free Cash Flow | 8/10 |